Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

specific

A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.

55

Centers

31

Active Trials

Cancer Funding

Top Centers for Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1(55)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
60.7
2
NCI Comprehensive
Active Research Program
60.7
3
NCI Comprehensive
Active Research Program
60.7
4
NCI Comprehensive
Active Research Program
60.7
5
NCI Comprehensive
Active Research Program
60.7
6
NCI Comprehensive
Active Research Program
60.7
7
NCI Comprehensive
Active Research Program
60.7
8
NCI Comprehensive
Active Research Program
60.7
9
NCI Comprehensive
Active Research Program
60.7
10
NCI Comprehensive
Active Research Program
60.7
11
NCI Comprehensive
Active Research Program
60.7
1260.7
13
NCI Comprehensive
Active Research Program
60.7
14
NCI Comprehensive
Active Research Program
60.7
15
NCI Comprehensive
Active Research Program
60.7
16
NCI Clinical
Active Research Program
60.7
17
NCI Comprehensive
Active Research Program
60.7
18
NCI Comprehensive
Active Research Program
60.7
19
NCI Clinical
Active Research Program
60.7
20
NCI Comprehensive
Active Research Program
60.7
21
Active Research Program
60.7
22
Active Research Program
60.7
23
NCI Comprehensive
Active Research Program
60.7
24
Active Research Program
60.7
25
NCI Comprehensive
Active Research Program
60.7
26
Active Research Program
60.7
27
Active Research Program
60.7
28
Active Research Program
60.7
29
Active Research Program
60.7
30
Active Research Program
60.7
31
Active Research Program
60.7
32
NCI Comprehensive
38.2
33
NCI Comprehensive
38.2
34
NCI Comprehensive
38.2
3538.2
36
NCI Comprehensive
38.2
3738.2
3838.2
39
NCI Comprehensive
38.2
4038.2
4138.2
4238.2
43
NCI Comprehensive
38.2
44
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
38.2
4538.2
4638.2
4738.2
4838.2
4938.2
5038.2
5138.2
5238.2
5338.2
54
BC CancerVancouver, BC
38.2
5538.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →